Clinical trial Recruiting at 1 site Interventional Ages 3 to 6

AI-assisted DIMS glasses to stop myopia in young children with pre-myopia

Official title: Managing Premyopia in Chinese Children Using Artificial Intelligence Assisted Defocus Incorporated Multiple Segments Based Spectacle Lens: a Randomized Controlled Clinical Trial

Run by Shanghai Eye Disease Prevention and Treatment Center · NCT07765550 · Data updated 2026-11-12

This trial tests whether AI-assisted DIMS-style glasses can help prevent myopia in children aged 3–6 who are at risk.

More Myopia trials

Quick facts

Study typeInterventional
Ages3 Years to 6 Years
SexAll
Enrollment128 (estimated)
SponsorShanghai Eye Disease Prevention and Treatment Center
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedSeptember 12, 2026
Main results expectedMay 31, 2028
Study endsAugust 31, 2028
Registry record updatedNovember 6, 2026
Trial IDNCT07765550 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 3–6 years old with hyperopic reserve between >-0.50 D and ≤+0.75 D, low cylindrical error, anisometropia ≤1.5 D, and at least one parent with SER ≤ -3.00 D.

Probably not a fit

Some children may not experience slowed progression due to individual variation or non-compliance with lens wear.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a parallel-design, open-label, randomized controlled trial conducted at a single center in Shanghai. Children aged 3–6 with low hyperopic reserve will be assigned to receive AI-assisted defocus-incorporated multi-segment spectacle lenses or control treatment, to see if myopia progression can be slowed or prevented. The study uses AI-powered optimization of lens defocus in the DIMS framework and includes safety monitoring and standard refractive outcomes. A secondary component includes smartwatches to support adherence and monitoring of visual behaviors.

Why it matters

Potential benefit: If successful, children receiving the AI-assisted DIMS lenses may have a lower risk of progressing toward myopia.

How similar studies have gone: Prior DIMS-style approaches have shown promise in delaying myopia onset/progression; this AI-enhanced approach is a novel refinement.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 3 and 6 years (inclusive), regardless of gender or ethnicity.
* Cycloplegic spherical equivalent refraction (SER) of the worse eye \> -0.50 D and ≤ +0.75 D, absolute cylindrical power ≤ 1.0 D, anisometropia ≤ 1.5 D.
* Best corrected monocular distance high contrast VA ≥ 0.5 for ages 3-5; ≥ 0.7 for age 6.
* At least one parent with SER ≤-3.00D

Exclusion Criteria:

* Individuals with any ocular or systemic diseases that may affect vision and refractive development (e.g., keratoconus, abnormalities in lens shape or position, Marfan syndrome, retinopathy of prematurity, etc.).
* Individuals with known allergies or contraindications to cycloplegic agents.
* Previous use of myopia management treatment (spectacles, atropine; CLs).
* Individuals with binocular vision abnormalities: manifest strabismus, monocular suppression, abnormal fusion function, or impaired stereopsis.
* Individuals unable to cooperate with examinations or communicate.
* Any other conditions deemed by the investigator as unsuitable for participation in the study.

Where it's running

  • Shanghai Eye Disease Prevention and Treatment Center
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: He, Prof — Shanghai Eye Disease Prevention and Treatment Center
  • Study coordinator: Xiangui He, Prof
  • Email: xianhezi@163.com
  • Phone: +86 15000755422

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.